Key result
Familial LCAT deficiency links to abnormal LP-X presence and reduced ApoA, ApoB, and ApoD levels.
Observational
Answers are grounded in this paper and cite their sources.
The plasma lipoprotein system in patients with familial LCAT deficiency contains all the polypeptides and lipoprotein families identified previously in plasma lipoproteins of normal subjects. There are, however, some qualitative and quantitative differences. The most significant qualitative difference is the presence in LCAT-deficient plasma of LP-X, the abnormal low density lipoprotein species characteristic of obstructive jaundice. The major quantitative difference is the reduced concentration of ApoA, ApoB, and ApoD in LCAT-deficient plasma. It has already been demonstrated that most lipoprotein species in LCAT deficiency have an abnormal lipid composition characterized by unusually high contents of unesterified cholesterol and lecithin and a negligible amount of esterified cholesterol (4). These abnormalities of the lipoprotein system in familial LCAT deficiency seem to result from the virtual absence of LCAT activity rather than from the absence of normally occurring lipoprotein families or their constitutive polypeptides.
No takes yet. Share an insight, caveat, or question.
Alaupovic et al. (1974) conducted an observational in Familial lecithin:cholesterol acyltransferase (LCAT) deficiency. Familial LCAT deficiency vs. Normal subjects was evaluated on Plasma apolipoprotein and lipoprotein family composition. Familial LCAT deficiency features abnormal LP-X presence and reduced ApoA, ApoB, and ApoD concentrations despite retaining all normal lipoprotein families.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: